Kallikrein Inhibitors [MoA] - N0000184151

Pharmacologic Class Information

Pharmacologic Code N0000184151
Pharmacologic Name Kallikrein Inhibitors
Pharmacologic Uses
  • human C1 esterase inhibitor
  • plasma kallikrein inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Kallikrein Inhibitors

The following table contains 4 products whose active ingredient are classified under the same pharmacologic class Kallikrein Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
42227-081Cinryze Non-Proprietary Name: Human C1-esterase InhibitorInjection, Powder, Lyophilized, For SolutionIntravenousViropharma Biologics LlcACTIVE
47783-101Kalbitor Non-Proprietary Name: EcallantideInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
47783-644Takhzyro Non-Proprietary Name: Lanadelumab-flyoInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
47783-646Takhzyro Non-Proprietary Name: Lanadelumab-flyoSolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE